Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) remains a common and difficult cancer to treat. Surgical resection and chemotherapy are standard of care and clinical outcomes remain poor. Oncolytic adenoviruses are a unique approach to the treatment of this challenging cancer, aiming to overcome th...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Isobel P., Lopez, J. Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374677/
https://www.ncbi.nlm.nih.gov/pubmed/37031291
http://dx.doi.org/10.1007/s00432-023-04735-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374677/
https://www.ncbi.nlm.nih.gov/pubmed/37031291
http://dx.doi.org/10.1007/s00432-023-04735-w

Ejemplares similares